ELDN Financials
Eledon Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$3.04
Market Cap
$209.63M
P/E Ratio
-4.1
EPS
$-1.30
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-36.18M
EPS (Diluted)
$-0.75
Balance Sheet Highlights
Total Assets
$177.41M
Total Liabilities
$59.27M
Shareholders Equity
-
Cash & Equivalents
$20.55M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-47.27M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-95.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ELDN revenue?
View ELDN's income statement for detailed revenue data.
Is ELDN profitable?
ELDN reported a loss of $36.18M in the most recent quarter.
What is ELDN market cap?
ELDN has a market capitalization of $209.63M, making it a small-cap stock.
Does ELDN have debt?
View ELDN's balance sheet for debt information.
What is ELDN cash flow?
Cash flow data is available in the full financial statements.